Journal of radiological science and technology (대한방사선기술학회지:방사선기술과학)

Korean Society of Radiological Science (대한방사선과학회)
권호 표지
DOI QR코드

DOI QR Code

The Study on Risk Factor of Metabolic Diseases in Pancreatic Steatosis

췌장지방증에서 대사성질환의 위험 요인에 관한 연구

  • Cho, Jin-Young (Dept. of Diagnosis Radiation, Wellness Hospital) ;
  • Ye, Soo-Young (Dept. of Radiological Science, College of Health Sciences, Catholic University of Pusan) ;
  • Kim, Dong-Hyun (Dept. of Radiological Science, College of Health Sciences, Catholic University of Pusan)
  • 조진영 (웰니스 병원) ;
  • 예수영 (부산가톨릭대학교 보건과학대학 방사선학과) ;
  • 김동현 (부산가톨릭대학교 보건과학대학 방사선학과)
  • Received : 2016.01.31
  • Accepted : 2016.03.16
  • Published : 2016.03.31
Download PDF
⟨ Previous Next ⟩

Abstract

The body of the fat tissue increased in obese represented by risk factors such as cardiovascular diseases, diabetes, metabolic disease and dyslipidemia. Such metabolic diseases and the like of the cardiovascular and cerebrovascular disease, hypertension, dyslipidemia, increase in the adipose tissue of the pancreas is known to be a risk factor of these diseases. Study on the diagnosis and treatment of pancreatic cancer was conducted actively, case studies on pancreatic steatosis is not much. In this study, divided into a control group diagnosed with pancreatic steatosis as a result of ultrasonography to evaluation the physical characteristics and serologic tests and blood pressure and arterial stiffness. The control group and the test pancreas steatosis age and waist circumference, body mass index, total cholesterol, HDL cholesterol, LDL cholesterol, and systolic and diastolic blood pressure, fasting blood glucose, arterial elasticity is higher in pancreatic steatosis. And the lower ankle brachial stenosis and HDL-cholesterol were lower than the normal control group, so the pancreatic steatosis harmful to blood vessels.(P <0.05). The difference between the control group and it was confirmed that the pancreatic jibanggun statistically significant. In conclusion, pancreatic steatosis at abdominal ultrasound can predict the risk of metabolic diseases, and there was a correlation with cardiovascular disease.

인체의 지방조직이 증가하여 비만해지면 심혈관계 질환, 당뇨병, 대사성질환과 이상지질혈증 등의 위험인자로 나타난다. 이러한 대사성질환에는 심혈관 및 뇌혈관질환, 고혈압, 고지혈증 등이 있고, 췌장의 지방조직 증가는 이러한 질환의 위험요인으로 알려져 있다. 그리고 췌장암에 대한 진단과 치료에 대한 연구는 활발히 이루어졌으나, 췌장지방증에 관한 연구 사례는 많지 않다. 본 연구에서는 초음파 검사의 결과로 진단된 췌장지방군과 정상대조군으로 나누어 신체 특성과 혈청학적 검사와 혈압 및 동맥경화도검사를 평가하였다. 정상대조군과 췌장지방군 사이에서 연령이나 허리둘레, 체질량 지수, 총 콜레스테롤, HDL 콜레스테롤과 LDL 콜레스테롤, 수축기와 이완기혈압, 공복혈당, 대동맥 맥파전파속도는 췌장지방군에서 높게 나타났다. 그리고 족관절상완협착비와 HDL-콜레스테롤은 낮을수록 혈관에 유해하므로 췌장지방군이 정상대조군보다 낮게 나타났다(p < 0.05). 정상대조군과 췌장지방군의 차이가 통계적으로 유의함을 확인할 수 있었다. 결론적으로 복부초음파 검사에서 췌장지방증은 대사성 질환의 위험을 예측할 수 있으며 심혈관계 질환과 연관성이 있었다.

Keywords

References

  1. Ho Gak Kim, Jimin Han, "Obesity and Pancreatic Diseases", Korean J Gastroenterol 59(1), 35-39, 2012 https://doi.org/10.4166/kjg.2012.59.1.35
  2. Nilgun lsiksalan Ozbulbul, Mehmet Yurdakul, Muharrem Tola, "Does the viceral fat tissue show better correlation with the fatty replacement of the pancreas than with BMI?", Euasian J Med, 42(1), 24-27, 2010
  3. Deniz Altine, Olca Basturk, Juan M. Sarmiento, Diego Martin, et al, "Lipomatous Pseudohypertrophy of the Pancreas: A Clinicopathologically Distinct Entity", Health of national institutes, 39(3), 392-397, 2010
  4. Y Lee. I Lingvay, LS Szczepaniak, M Ravazzola, L Orci and RH Unger, "Pancreatic steatosis: harbinger of type 2 diabetes in obese rodents", International Journal of Obesity, 34, 396-400, 2010 https://doi.org/10.1038/ijo.2009.245
  5. Wan-Chen Wu,, Chih Yuan Wang, "Association between non-alcoholic fatty pancretic disease(nafpd) and metabolic syndrome: case-control retrospective study", Cadiovascular Diabetology, 12(77), 2013
  6. W Yin, D Liao, M Kusunoki, S Xi, K Tsutsumi, Z Wang, X Lian, T Koike, J Fan, Y Yang and C Tang, "NO-1886 decreases ectopic lipid deposition and protects pancreatic ${\beta}$ cells in diet-induced diabetic swine", Journal of Endocrinology, 180, 399-408, 2004 https://doi.org/10.1677/joe.0.1800399
  7. Sang Hum Kim, "Fatty pancreas on abdominal ultrasonogram: Relationships to clinical characteristics and metabolic syndrome", Department of medicine, Univercity of Hangyang gradudate school, 11-22, 2008
  8. W Yin, D Liao, M Kusunoki, S Xi, K Tsutsumi, Z Wang, X Lian, T Koike, J Fan, Y Yang and C Tang, "NO-1886 decreases ectopic lipid deposition and protects pancreatic ${\beta}$ cells in diet-induced diabetic swine", J of Endocrinology, 180(3), 399-408, 2004 https://doi.org/10.1677/joe.0.1800399
  9. Sepe PS, Ohri A, Sanaka S, Berzin TM, Sekhon S, Bennett G, Chuttani R, Kane R, Pleskow D, et al: "A prospective evalution of fatty pancreas by using EUS", Gastrointest Endoscopy, 73(5), 987-993, 2011 https://doi.org/10.1016/j.gie.2011.01.015
  10. Su Yun Kim, Kyung Won Shim, Hong Su Lee, Sang Hwa Lee, Hye Lim Kim, Young Ah Oh,, "The Association of Nonalcoholic Fatty Liver Disease with Metabolic Syndrome", JKAFM, 28(9), 667-674, 2007
  11. Sang Hyun Kim, "Cholesterol, Metabolic Syndrome and Arteriosclerosis", Korean Society of Lipidology and Atherosclerosis, 1-6, 2012
  12. Jee SH, Jang Y, Oh BH, Lee SH, Park, SW, et al. "A coronary heart disease prediction model: the Korean Heart Study", BMJ Open, 4(5), 2014
  13. Young Sul Kim, Hyun Ho Kim, Mun Gyu Lee, Heon Taek Chung, Sung Seol Chae, " Korea Guidelines for Dyslipidemia 2015", Korean Society of Lipidology and Atherosclerosis, 3-21, 2015
  14. Grundy SM, CLeeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunnighake DB, et al. "Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panal III guidelines", Circulation, 44(3), 227-239, 2004
  15. Da Hye Kim, "The Relation of Nonalcoholic Fatty Liver Disease to Metabolic Syndrome", 3-12, 2011
  16. Scott M. Grundy, M.D., Diane Becker, Sc.D., M.P.H., R.N., Luther T. Clark, M.D., Richard S. Cooper, M.D., et al. "Third Report of the National Cholesterol Education Program(NCEP) Expert Panel on Detection, Evalution, and Treatment of High Blood Cholesterol in Adults final report", Circulation, 106(25), 3143-3421, 2002
  17. Chalasani N, Deeg MA, Pershn S, et al. "Metabolic and anthropometric evalution of insulin resistance in nondiabetic patients with nonalcoholic steatohepatitis", Am J Gastroenterol, 98, 1849-1855, 2003 https://doi.org/10.1111/j.1572-0241.2003.07619.x
  18. Sat Byul Park, "The Relation of Cardiovascular Risk Factors to Metabolic Syndrome", J Korean Acad Fam Med, 26(10), 614-620, 2005
  19. Horng-Yih Ou, Chih-Yuan Wang, Yi-Ching Yang, Ming-Fong Chen, Chih-Jen Chang, "The Association between Nonalcoholic Fatty Pancreas Disease and Diabetes",PLOS ONE, 8(5), 1-8, 2013
  20. Varayu Prachayakul, Pitulak Aswakul, "Pancreatic Steatosis: What Should Gastroenterologists Know?", JOP. Journal of pancreas, 16(3), 227-231, 2015
  21. JS. Lee, SH. Kim, DW. Jun, JH. Han, et al, "Clinical implications of fatty pancreas: Correlations between fatty pancreas and metabolic syndrome", World J Gastroenterology, 15(15), 1869-1875, 2009 https://doi.org/10.3748/wjg.15.1869
  22. Seonghyeop Hyeon, "The association between fatty liver and pericardial fat in overweight or obese subjects", Department of medicine, Graduate School Chung-Ang University College of Medicine, Seoul, 6-11, 2012